Current position:Home >Product >
Bone morphogeneticprotein 7, prepro- (human clone HH(dT+R)-1 reduced)
Bone morphogeneticprotein 7, prepro- (human clone HH(dT+R)-1 reduced)(129805-33-0)
- Name: Bone morphogeneticprotein 7, prepro- (human clone HH(dT+R)-1 reduced)
- Synonyms:10: PN:WO0174379 SEQID: 2 claimed protein; 11: PN: WO0066620 SEQID: 2 unclaimedprotein; 1: PN: WO0029012 SEQID: 2 claimed protein; 2: PN: WO0123563 SEQID: 2unclaimed protein; 34: PN: WO0020449 SEQID: 39 unclaimed protein; 38: PN:WO0020607 SEQID: 39 claimed protein; 39: PN: WO0020591 SEQID: 39 claimedprotein; 3: PN: US6110482 SEQID: 2 unclaimed protein; 3: PN: WO0066620 SEQID: 3claimed protein; 7: PN: WO0020021 SEQID: 2 unclaimed protein; Bonemorphogenetic protein 7 (human precursor); Bone morphogenetic protein 7(human); Bone morphogenetic protein 7, prepro- (human); Eptotermin alfa;Glycoprotein (human clone PEH7-9 bone morphogenetic 7 subunit precursor proteinmoiety reduced); Glycoprotein OP 1, prepro- (human clone HH(dT+R)-1 osteogenicprotein moiety reduced); Glycoprotein, prepro- (human clone morphogenetic 7subunit protein moiety reduced); OP-1 (human); Osteogenic protein 1 (human);Protein OP 1 (human brain osteogenic); Protein OP-1 (human osteogenicprotein-1); osteogenic protein X, prepro- (human)
- Molecular Formula:
- Molecular Weight:
- CAS Registry Number:129805-33-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.129805-33-0 eptotermin alfa
Assay:97% Appearance:white crystalline powder Package:according to the clients requirement Storage:Room temperature with sealed well Transportation:by sea or by air Application:Use as primary and secondary intermediate
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 53414-36-1/1,3-dicyclohexyl-5,5-di(prop-2-en-1-yl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
- 63544-15-0/2-chloro-N-(2-chloroethyl)-N-methyl-ethanamine; dichloroplatinum
- 101-59-7/4-AMINO-4'-NITRODIPHENYL SULFIDE
- 39430-27-8/NICKEL(II) CARBONATE BASIC TETRAHYDRATE
- 58524-83-7/ciprocinonide
- 332102-25-7/1-ACETYL-3,5-DIPHENYLPYRAZOLIDINE
- 509-30-8/(6S,9S,13cS)-6-methyl-10-methylidenedodecahydro-5H-8a,11-methano-6,13b-propanocyclohepta[h][1,3]oxazolo[2,3-a]isoquinolin-9(13cH)-ol
- 2304-98-5/Z-ARG(NO2)-OH
- 114607-46-4/Acitazanolast
- 18722-71-9/Bis(dimethylamino)4-piperidylphosphine oxide
- 79-81-2/Retinol palmitate
- 102242-87-5/Copper,[29H,31H-phthalocyaninato(2-)-kN29,kN30,kN31,kN32]-, aminosulfonyl[[2-[[4-(3-carboxypyridinio)-6-methoxy-1,3,5-triazin-2-yl]amino]ethyl]amino]sulfonylsulfo derivs., inner salts, sodium salts
- 55618-66-1/Piperidinium, 1,1-(p,p-biphenylylenebis(3-methyl-2-butenylene))bis(1-carboxymethyl-, dichloride, dimethyl ester
- 87866-18-0/7-amino-1H-[1,2,3]triazolo[4,5-d]pyrimidine-5-thiol
- 376348-65-1/Maraviroc
- 129805-33-0/Bone morphogeneticprotein 7, prepro- (human clone HH(dT+R)-1 reduced)
- 122005-23-6/KS 504d
- 1333-49-9/dimethyloctan-2-ol
- 17640-15-2/METHYL CYANOFORMATE
- 80382-23-6/Loxoprofen sodium
- 71672-75-8/2-ETHOXYBENZYL ALCOHOL
- 19150-71-1/octadecyl acetoacetate
- 78-35-3/LINALYL ISOBUTYRATE
- 22990-19-8/1-Phenyl-1,2,3,4-tetrahydro-isoquinoline
- 53317-48-9/(1Z)-1,2,3-trichlorobuta-1,3-diene
- 9016-00-6/Poly(dimethylsiloxane)
- 39937-47-8/Gitonin
- 68401-82-1/Ceftizoxime sodium
- 116-76-7/1,4-bis[(9,10-dihydro-9,10-dioxo-1-anthryl)amino]anthraquinone
- 113262-62-7/Spiro[5.5]undeca-7,9-dien-3-ol,2-bromo-1,1,9-trimethyl-5-methylene-, (2R,3S,6R)-